Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,041 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Evaluation of sequence ambiguities of the HIV-1 pol gene as a method to identify recent HIV-1 infection in transmitted drug resistance surveys.
Andersson E, Shao W, Bontell I, Cham F, Cuong do D, Wondwossen A, Morris L, Hunt G, Sönnerborg A, Bertagnolio S, Maldarelli F, Jordan MR. Andersson E, et al. Among authors: morris l. Infect Genet Evol. 2013 Aug;18:125-31. doi: 10.1016/j.meegid.2013.03.050. Epub 2013 Apr 11. Infect Genet Evol. 2013. PMID: 23583545 Free PMC article.
HIV-1 Subtype A, D, G, AG and unclassified sequences identified in South Africa.
Bredell H, Hunt G, Casteling A, Cilliers T, Rademeyer C, Coetzer M, Miller S, Johnson D, Tiemessen CT, Martin DJ, Williamson C, Morris L. Bredell H, et al. Among authors: morris l. AIDS Res Hum Retroviruses. 2002 Jun 10;18(9):681-3. doi: 10.1089/088922202760019400. AIDS Res Hum Retroviruses. 2002. PMID: 12079566
World Health Organization/HIVResNet Drug Resistance Laboratory Strategy.
Bertagnolio S, Derdelinckx I, Parker M, Fitzgibbon J, Fleury H, Peeters M, Schuurman R, Pillay D, Morris L, Tanuri A, Gershy-Damet GM, Nkengasong J, Gilks CF, Sutherland D, Sandstrom P. Bertagnolio S, et al. Among authors: morris l. Antivir Ther. 2008;13 Suppl 2:49-57. Antivir Ther. 2008. PMID: 18575191
Persistent minority K103N mutations among women exposed to single-dose nevirapine and virologic response to nonnucleoside reverse-transcriptase inhibitor-based therapy.
Coovadia A, Hunt G, Abrams EJ, Sherman G, Meyers T, Barry G, Malan E, Marais B, Stehlau R, Ledwaba J, Hammer SM, Morris L, Kuhn L. Coovadia A, et al. Among authors: morris l. Clin Infect Dis. 2009 Feb 15;48(4):462-72. doi: 10.1086/596486. Clin Infect Dis. 2009. PMID: 19133804 Free PMC article.
Rapid development of antiretroviral drug resistance mutations in HIV-infected children less than two years of age initiating protease inhibitor-based therapy in South Africa.
Taylor BS, Hunt G, Abrams EJ, Coovadia A, Meyers T, Sherman G, Strehlau R, Morris L, Kuhn L. Taylor BS, et al. Among authors: morris l. AIDS Res Hum Retroviruses. 2011 Sep;27(9):945-56. doi: 10.1089/aid.2010.0205. Epub 2011 Mar 23. AIDS Res Hum Retroviruses. 2011. PMID: 21345162 Free PMC article.
Genotypic resistance at viral rebound among patients who received lopinavir/ritonavir-based or efavirenz-based first antiretroviral therapy in South Africa.
Dlamini JN, Hu Z, Ledwaba J, Morris L, Maldarelli FM, Dewar RL, Highbarger HC, Somaroo H, Sangweni P, Follmann DA, Pau AK; Phidisa II Study Team. Dlamini JN, et al. Among authors: morris l. J Acquir Immune Defic Syndr. 2011 Nov 1;58(3):304-8. doi: 10.1097/QAI.0b013e3182278c29. J Acquir Immune Defic Syndr. 2011. PMID: 21694608 Free PMC article. Clinical Trial.
2,041 results